Clinical Trial

Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment

Study acronym: IDV of tau-PET
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to investigate the clinical validity of tau-PET with \[18F\]RO948 vs. amyloid-PET in patients with Mild Cognitive Impairment (MCI) or mild dementia
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-27; most recent amendment 2025-12-16.
Status change: Not Yet Recruiting → Recruiting 2025-01-06
Trial Details
NCT Number NCT06618872
Lead Sponsor University Hospital, Geneva
Collaborators: Centre Hospitalier Universitaire Vaudois
Conditions Dementia, Alzheimer Disease
Enrollment 120 participants
Start Date 2024-12-03
Primary Completion 2027-08-30 (estimated)
Study Completion 2027-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-23